Monument Therapeutics is a precision neuroscience company focused on developing innovative treatments for cognitive symptoms of schizophrenia. Their lead product, MT1988, aims to address the significant unmet medical needs associated with cognitive impairments in schizophrenia, complementing existing therapies in the field.
Leadership & Board
Current Number of Employees6
Current LinkedIn Followers3,026
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$1M
Total Amount Raised$1M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$1M
Latest Funding Amount$1M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Monument Therapeutics had 6 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
6Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Monument Therapeutics had 3,026 followers as of October 5, 2026. The number of followers increased by 15 (0.50%) week-over-week.
3,026Latest Followers Count
15(0.50%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.